1. Home
  2. CCB vs PHVS Comparison

CCB vs PHVS Comparison

Compare CCB & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCB
  • PHVS
  • Stock Information
  • Founded
  • CCB 1997
  • PHVS 2015
  • Country
  • CCB United States
  • PHVS Switzerland
  • Employees
  • CCB N/A
  • PHVS N/A
  • Industry
  • CCB Major Banks
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCB Finance
  • PHVS Health Care
  • Exchange
  • CCB Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • CCB 1.8B
  • PHVS 1.6B
  • IPO Year
  • CCB 2018
  • PHVS 2021
  • Fundamental
  • Price
  • CCB $102.75
  • PHVS $23.72
  • Analyst Decision
  • CCB Strong Buy
  • PHVS Buy
  • Analyst Count
  • CCB 4
  • PHVS 6
  • Target Price
  • CCB $113.75
  • PHVS $36.50
  • AVG Volume (30 Days)
  • CCB 127.2K
  • PHVS 248.0K
  • Earning Date
  • CCB 10-27-2025
  • PHVS 11-12-2025
  • Dividend Yield
  • CCB N/A
  • PHVS N/A
  • EPS Growth
  • CCB 18.14
  • PHVS N/A
  • EPS
  • CCB 3.25
  • PHVS N/A
  • Revenue
  • CCB $336,394,000.00
  • PHVS N/A
  • Revenue This Year
  • CCB $83.27
  • PHVS N/A
  • Revenue Next Year
  • CCB $35.03
  • PHVS N/A
  • P/E Ratio
  • CCB $31.66
  • PHVS N/A
  • Revenue Growth
  • CCB 28.83
  • PHVS N/A
  • 52 Week Low
  • CCB $58.41
  • PHVS $11.51
  • 52 Week High
  • CCB $119.22
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • CCB 41.98
  • PHVS 54.68
  • Support Level
  • CCB $98.80
  • PHVS $20.65
  • Resistance Level
  • CCB $104.37
  • PHVS $22.90
  • Average True Range (ATR)
  • CCB 4.02
  • PHVS 1.40
  • MACD
  • CCB -0.98
  • PHVS 0.00
  • Stochastic Oscillator
  • CCB 26.34
  • PHVS 85.38

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: